Compare Pfizer with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs TORRENT PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER TORRENT PHARMA PFIZER/
TORRENT PHARMA
 
P/E (TTM) x 36.4 39.1 93.1% View Chart
P/BV x 6.2 8.5 73.4% View Chart
Dividend Yield % 0.5 0.7 76.4%  

Financials

 PFIZER   TORRENT PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-19
TORRENT PHARMA
Mar-19
PFIZER/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs3,8401,964 195.5%   
Low Rs2,0801,245 167.1%   
Sales per share (Unadj.) Rs455.0453.4 100.3%  
Earnings per share (Unadj.) Rs93.825.8 363.7%  
Cash flow per share (Unadj.) Rs109.462.3 175.6%  
Dividends per share (Unadj.) Rs22.5017.00 132.4%  
Dividend yield (eoy) %0.81.1 71.7%  
Book value per share (Unadj.) Rs658.2279.2 235.8%  
Shares outstanding (eoy) m45.75169.22 27.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.53.5 183.9%   
Avg P/E ratio x31.662.2 50.7%  
P/CF ratio (eoy) x27.125.8 105.0%  
Price / Book Value ratio x4.55.7 78.2%  
Dividend payout %24.065.9 36.4%   
Avg Mkt Cap Rs m135,420271,513 49.9%   
No. of employees `0002.613.6 19.3%   
Total wages/salary Rs m3,23814,038 23.1%   
Avg. sales/employee Rs Th7,911.45,642.6 140.2%   
Avg. wages/employee Rs Th1,230.91,032.4 119.2%   
Avg. net profit/employee Rs Th1,630.7320.9 508.2%   
INCOME DATA
Net Sales Rs m20,81576,728 27.1%  
Other income Rs m1,674571 293.4%   
Total revenues Rs m22,48977,299 29.1%   
Gross profit Rs m5,71219,831 28.8%  
Depreciation Rs m7146,177 11.6%   
Interest Rs m735,038 1.4%   
Profit before tax Rs m6,5999,187 71.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m2,3091,254 184.2%   
Profit after tax Rs m4,2914,363 98.3%  
Gross profit margin %27.425.8 106.2%  
Effective tax rate %35.013.6 256.4%   
Net profit margin %20.65.7 362.5%  
BALANCE SHEET DATA
Current assets Rs m27,16750,375 53.9%   
Current liabilities Rs m8,91751,653 17.3%   
Net working cap to sales %87.7-1.7 -5,264.7%  
Current ratio x3.01.0 312.4%  
Inventory Days Days6892 73.7%  
Debtors Days Days3068 44.1%  
Net fixed assets Rs m8,86283,648 10.6%   
Share capital Rs m458846 54.1%   
"Free" reserves Rs m29,65646,397 63.9%   
Net worth Rs m30,11347,244 63.7%   
Long term debt Rs m2539,129 0.1%   
Total assets Rs m39,400141,209 27.9%  
Interest coverage x91.52.8 3,241.3%   
Debt to equity ratio x00.8 0.1%  
Sales to assets ratio x0.50.5 97.2%   
Return on assets %11.16.7 166.4%  
Return on equity %14.29.2 154.3%  
Return on capital %22.112.3 179.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42822,103 1.9%   
Fx outflow Rs m7865,522 14.2%   
Net fx Rs m-35816,581 -2.2%   
CASH FLOW
From Operations Rs m97817,981 5.4%  
From Investments Rs m351-2,413 -14.6%  
From Financial Activity Rs m-1,099-13,145 8.4%  
Net Cashflow Rs m2312,380 9.7%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 7.0 106.8%  
FIIs % 4.9 12.6 38.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.8 269.3%  
Shareholders   85,207 26,511 321.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 307 Points Higher; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets traded on a positive note throughout the day and ended higher, tracking positive global sentiments.

Related Views on News

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020(Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

Why We Picked This Smallcap Stock for a Post Coronavirus World(Profit Hunter)

May 28, 2020

Covid-19 has made it a survival of the fittest race for many companies. The ones that can adapt will thrive in a post crisis world.

What the RBI's Rate Cut Means for Options Traders(Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Who Will Be Crowned the 'Multibagger Blue Chip' of the Decade?(Profit Hunter)

May 25, 2020

Will the mutlibagger blue chips of the past decade continue to rule the bourses?

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jun 5, 2020 (Close)

TRACK PFIZER

PFIZER - ORCHID PHARMA LTD COMPARISON

COMPARE PFIZER WITH

MARKET STATS